FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products approved in 2021 by the FDA. Approval of biosimilar products can increase patient access to safe and effective treatment options.
News Medical on MSN9d
How olive oil bioactives regulate genes linked to insulin resistanceOlive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity ...
Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.
A new systematic review and meta-analysis published in the Clinical Nutrition ESPEN revealed promising outcomes for the ...
News Medical on MSN12d
Improving insulin sensitivity with regular mango consumptionA recently study published in Nutrients reports that the regular consumption of mangoes may improve inflammation, insulin ...
Study results indicated that controlling diabetes with insulin helps to prevent the emergence of antibiotic-resistant S. aureus.
A new study published in the journal BMC Pregnancy and Childbirth has found that variations in serum ferritin levels across ...
News Medical on MSN8d
A pathway that contributes to insulin resistance can be targeted, mouse study showsThe hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study. Blocking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback